Isoenzyme specific PFK-2/FBPas-2 inhibition as an anti-cancer strategy
<p>High aerobic glycolytic capacity is correlated with poor prognosis and increased tumour aggressiveness. 6Phosphofructo-1-kinase catalyses the first irreversible step of glycolysis, and is activated by fructose-2,6-bisphosphate, a product of the kinase activity of four bifunctional isoenzyme...
Egile nagusia: | Williams, J |
---|---|
Beste egile batzuk: | Harris, A |
Formatua: | Thesis |
Hizkuntza: | English |
Argitaratua: |
2013
|
Gaiak: |
Antzeko izenburuak
-
Isoenzyme-specific PFK-2/FBPase-2 Inhibition as an Anti-cancer Strategy
nork: Williams, J, et al.
Argitaratua: (2012) -
Design, synthesis and biological evaluation of glycosidase inhibitors in an anti-cancer setting
nork: Glawar, AFG
Argitaratua: (2013) -
Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
nork: Potter, M
Argitaratua: (2014) -
Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/neu in breast cancer and is an independent predictor of prognosis
nork: Winters, Z, et al.
Argitaratua: (2003) -
The synthesis and biological evaluation of novel N-acetylhexosaminidase inhibitors
nork: Crabtree, E, et al.
Argitaratua: (2011)